Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group
Price, D JA, Campbell, P G, Sutton, A GC, Grech, E D, Davies, A, Hall, J A, De Belder, M A
Published in International journal of cardiovascular interventions (2001)
Published in International journal of cardiovascular interventions (2001)
Get more information
Journal Article